BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 12461744)

  • 21. Allele-specific loss of heterozygosity at the DAL-1/4.1B (EPB41L3) tumor-suppressor gene locus in the absence of mutation.
    Kittiniyom K; Mastronardi M; Roemer M; Wells WA; Greenberg ER; Titus-Ernstoff L; Newsham IF
    Genes Chromosomes Cancer; 2004 Jul; 40(3):190-203. PubMed ID: 15138999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and characterization of a homozygous deletion found in ovarian ascites by representational difference analysis.
    Watson JE; Gabra H; Taylor KJ; Rabiasz GJ; Morrison H; Perry P; Smyth JF; Porteous DJ
    Genome Res; 1999 Mar; 9(3):226-33. PubMed ID: 10077528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Case of interstitial 12q deletion in association with Wilms tumor.
    Rapley EA; Hargrave D; Persinguhe N; Barfoot R; Moore I; Radford M; Stratton MR; Rahman N; Pritchard-Jones K
    Am J Med Genet; 2001 Dec; 104(3):246-9. PubMed ID: 11754052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at distal 17p13.3 in human lung cancer.
    Konishi H; Sugiyama M; Mizuno K; Saito H; Yatabe Y; Takahashi T; Osada H; Takahashi T
    Oncogene; 2003 Mar; 22(12):1892-905. PubMed ID: 12660825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group.
    Grundy PE; Breslow NE; Li S; Perlman E; Beckwith JB; Ritchey ML; Shamberger RC; Haase GM; D'Angio GJ; Donaldson M; Coppes MJ; Malogolowkin M; Shearer P; Thomas PR; Macklis R; Tomlinson G; Huff V; Green DM;
    J Clin Oncol; 2005 Oct; 23(29):7312-21. PubMed ID: 16129848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A 700-kb physical and transcription map of the cervical cancer tumor suppressor gene locus on chromosome 11q13.
    Zainabadi K; Benyamini P; Chakrabarti R; Veena MS; Chandrasekharappa SC; Gatti RA; Srivatsan ES
    Genomics; 2005 Jun; 85(6):704-14. PubMed ID: 15885497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers.
    Mihaila D; Gutiérrez JA; Rosenblum ML; Newsham IF; Bögler O; Rempel SA;
    Clin Cancer Res; 2003 Oct; 9(12):4435-42. PubMed ID: 14555516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fine deletion mapping of chromosome 2q21-37 shows three preferentially deleted regions in oral cancer.
    Cengiz B; Gunduz M; Nagatsuka H; Beder L; Gunduz E; Tamamura R; Mahmut N; Fukushima K; Ali MA; Naomoto Y; Shimizu K; Nagai N
    Oral Oncol; 2007 Mar; 43(3):241-7. PubMed ID: 16857411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of heterozygosity and transcriptome analyses of a 1.2 Mb candidate ovarian cancer tumor suppressor locus region at 17q25.1-q25.2.
    Presneau N; Dewar K; Forgetta V; Provencher D; Mes-Masson AM; Tonin PN
    Mol Carcinog; 2005 Jul; 43(3):141-54. PubMed ID: 15937959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A dual-color FISH framework map for the characterization of the Sai1 tumor suppression region on rat chromosome 5.
    Helou K; Lü XC; Montelius-Alatalo K; Ståhl F; Klinga-Levan K; Levan G; Röhme D
    Genes Chromosomes Cancer; 2000 Apr; 27(4):362-72. PubMed ID: 10719366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genome-wide loss of heterozygosity analysis of WT1-wild-type and WT1-mutant Wilms tumors.
    Ruteshouser EC; Hendrickson BW; Colella S; Krahe R; Pinto L; Huff V
    Genes Chromosomes Cancer; 2005 Jun; 43(2):172-80. PubMed ID: 15761866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microallelotyping defines novel regions of loss of heterozygosity in uterine leiomyomas.
    Canevari Rde A; Pontes A; Rogatto SR
    Mol Carcinog; 2005 Mar; 42(3):177-82. PubMed ID: 15605361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A frequent deletion polymorphism on chromosome 22q13 identified by representational difference analysis of ovarian cancer.
    Lin H; Pizer ES; Morin PJ
    Genomics; 2000 Nov; 69(3):391-4. PubMed ID: 11056057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of three 11p11.2 candidate liver tumor suppressors through analysis of known human genes.
    Ricketts SL; Carter JC; Coleman WB
    Mol Carcinog; 2003 Feb; 36(2):90-9. PubMed ID: 12557265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic mosaicism in normal tissues of Wilms' tumour patients.
    Chao LY; Huff V; Tomlinson G; Riccardi VM; Strong LC; Saunders GF
    Nat Genet; 1993 Feb; 3(2):127-31. PubMed ID: 8388768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Definition of a minimal region of deletion of chromosome 7 in uterine leiomyomas by tiling-path microarray CGH and mutation analysis of known genes in this region.
    Vanharanta S; Wortham NC; Langford C; El-Bahrawy M; van der Spuy Z; Sjöberg J; Lehtonen R; Karhu A; Tomlinson IP; Aaltonen LA
    Genes Chromosomes Cancer; 2007 May; 46(5):451-8. PubMed ID: 17285575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased E-cadherin expression correlates with higher stage of Wilms' tumors.
    Safford SD; Freemerman AJ; Langdon S; Bentley R; Goyeau D; Grundy PE; Skinner MA
    J Pediatr Surg; 2005 Feb; 40(2):341-8. PubMed ID: 15750927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of a new homozygous deletion in the tumor suppressor region at 3p12.3 reveals two novel intronic noncoding RNA genes.
    Angeloni D; ter Elst A; Wei MH; van der Veen AY; Braga EA; Klimov EA; Timmer T; Korobeinikova L; Lerman MI; Buys CH
    Genes Chromosomes Cancer; 2006 Jul; 45(7):676-91. PubMed ID: 16607615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular cloning and characterization of LCRG1 a novel gene localized to the tumor suppressor locus D17S800-D17S930.
    Li Y; Chen Z
    Cancer Lett; 2004 Jun; 209(1):75-85. PubMed ID: 15145523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.